Novel alternative for the N-N bond formation through a PIFA-mediated oxidative cyclization and its application to the synthesis of indazol-3-ones

Journal of Organic Chemistry

Volumn 71, Issue 9, 2006, Pages 3501-3505

  Correa, Arkaitz ^a   Tellitu, Imanol ^a   Domínguez, Esther ^a   SanMartin, Raul ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINES; MOLECULAR ORIENTATION; NITROGEN COMPOUNDS; OXIDATION; SUBSTITUTION REACTIONS; SYNTHESIS (CHEMICAL);

HYPERVALENT IODINE; INDAZOLONE DERIVATIVES; INTRAMOLECULAR TRAPPING;

CHEMICAL BONDS;

AMINE; ANTHRANILIC ACID METHYL ESTER; HETEROCYCLIC COMPOUND; INDAZOL 3 ONE; INDAZOLE DERIVATIVE; IODINE DERIVATIVE; N ACYLNITRENIUM; NITROGEN; PHENYLIODINE BIS(TRIFLUOROACETATE); REAGENT; TRIFLUOROACETIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL BOND; CHEMICAL STRUCTURE; CYCLIZATION; OXIDATION; STRUCTURE ANALYSIS; SYNTHESIS;

EID: 33646271158     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo060070+     Document Type: Article

References (40)

1. (a) Nicolaou, K. C., Sorensen, E. J., Eds. In Classics in Total Synthesis; VCH Publishers: New York, 1995.
2. (b) Corey, E. J., Cheng, X.-M., Eds. In The Logic of Chemical Synthesis; John Wiley & Sons: New York, 1995.
3. (a) Kadlubar, K. K. In DNA Adducts Identification and Biological Significance; Hemmink, K., Dipple, A., Shugar, D. E. G., Segerback, D., Bartsch, H., Eds.; University Press: Oxford, U.K., 1994; pp 199-126.
4. (b) McClelland, R. A.; Ahmad, A.; Dicks, A. P.; Licence, V. E. J. Am. Chem. Soc. 1999, 121, 3303-3310.
5. For reviews concerning the chemistry of nitrenium ions, see: (a) Abramovitch, R. A.; Jeyaraman, R. In Azides and Nitrenes: Reactivity and Utility; Scriven, E. F. V., Ed.; Academic Press: Orlando, 1984; pp 297-357.
6. (b) Falvey, D. E. In Reactive Intermediate Chemistry; Moss, R. A., Platz, M. S., Jones, M., Eds.; Wiley-Interscience: Hoboken, NJ, 2004; pp 594-650.
7. (a) Glover, S. A.; Goosen, A.; McCleland, C. W.; Schoonraad, J. L. Tetrahedron 1987, 43, 2577-2592.
8. (b) Kikugawa, Y.; Nagashima, A.; Sakamoto, T.; Miyazama, E.; Shiiya, M. J. Org. Chem. 2003, 68, 6739-6744.
9. (c) Falvey, D. E.; Kung, A. C. J. Org. Chem. 2005, 70, 3127-3132.
10. Kawase, M.; Miyake, Y.; Sakamoto, T.; Shimada, M.; Kikugawa, Y. Tetrahedron 1989, 45, 1653-1660.
11. When the easily handled and environmentally friendly I(III) reagent is used, an undesirable aromatic chlorination process is avoided because prior chlorination is not required to generate acylnitrenium ions. See: Kikugawa, Y. Rev. Heteroatom Chem. 1996, 15, 263-299.
12. (a) Wardrop, D. J.; Zhang, W. Org. Lett. 2001, 3, 2353-2356.
13. (b) Wardrop, D. J.; Landrie, C. L.; Ortíz, J. A. Synlett 2003, 1352-1354.
14. (a) Wardrop, D. J.; Burge, M. S. Chem. Commun. 2004, 1230-1231.
15. (b) Correa, A.; Tellitu, I.; Domínguez, E.; Moreno, I.; SanMartin, R. J. Org. Chem. 2005, 70, 2256-2264.
16. (c) Wardrop, D. J.; Burge, M. S. J. Org. Chem. 2005, 70, 10271-10284.
17. (a) Serna, S.; Tellitu, I.; Domínguez, E.; Moreno, I.; SanMartin, R. Tetrahedron Lett. 2003, 44, 3483-3486.
18. (b) Serna, S.; Tellitu, I.; Domínguez, E.; Moreno, I.; SanMartin, R. Org. Lett. 2005, 7, 3073-3076.
19. (a) Tse, E.; Butner, L.; Huang, Y.; Hall, I. H. Arch. Pharm. Pharm. Med. Chem. 1996, 329, 35-40.
20. (b) Abouzid, K. A.; El-Abhar, H. S. Arch. Pharmacal Res. 2003, 1, 1-8.
21. Norman, M. H.; Rigdon, G. C.; Navas, F., III; Cooper, B. R. J. Med. Chem. 1994, 37, 2552-2563.
22. Wyrick, S. D.; Voorstad, P. J.; Cocolas, G.; Hall, I. H. J. Med. Chem. 1984, 27, 768-772.
23. Zhou, D.-Y.; Koike, T.; Suetsugu, S.; Onitsuka, K.; Takahashi, S. Inorg. Chim. Acta 2004, 357, 3057-3063.
24. Baiocchi, L.; Corsi, G.; Palazzo, G. Synthesis 1978, 633-648.
25. Bird, C. W.; Chng, J. C. W.; Rama, N. H.; Saeed, A. Synth. Commun. 1991, 21, 545-548.
26. For a comprehensive review of the chemistry of indazoles, see: Stadbauer, W. Sci. Synth. 2002, 12, 227-324.
27. For recent reviews on polyvalent iodine reagents, see: (a) Zhdankin, V. V.; Stang, P. J. Chem. Rev. 2002, 102, 2523-2284.
28. (b) Stang, P. J. J. Org. Chem. 2003, 68, 2997-3008.
29. (c) Wirth, T. Top. Curr. Chem. 2003, 224, 1-264.
30. (d) Tohma, H.; Kita, Y. Adv. Synth. Catal. 2004, 346, 111-124.
31. (e) Moriarty, R. M. J. Org. Chem. 2005, 70, 2893-2903.
32. (f) Wirth, T. Angew. Chem., Int. Ed. 2005, 44, 3656-3665.
33. Levin, J. I.; Turos, E.; Weinreb, S. M. Synth. Commun. 1982, 12, 989-993.
34. Romero, A. G.; Darlington, W. H.; McMillan, M. W. J. Org. Chem. 1997, 62, 6582-6587.
35. For a recent review on the general synthesis of amides, see: Montalbetti, C. A. G. N.; Falque, V. Tetrahedron 2005, 61, 10827-10852.
36. It is interesting to remark that some o-aminobenzamides have been reported to show antipsychotic activity. See: (a) Norman, M. H.; Navas, F., III; Thompson, J. B.; Rigdon, G. C. J. Med. Chem. 1996, 39, 4692-4703.
37. (b) Yee, Y. K.; Tebbe, A. L.; Linebarger, J. H.; Height, D. W.; Craft, T. J.; Gifford-Moore, D.; Goodson, T.; Herron, D. K.; Klimkowski, V. J.; Kyle, J. A.; Sawyer, J. S.; Smith, G. F.; Tinsley, J. M.; Towner, R. D.; Weir, L.; Wiley, M. R. J. Med. Chem. 2000, 43, 873-882. For further details of the preparation and spectral data of benzamides 2a-g, see the Supporting Information.
38. 3 failed to afford the desired primary amide, it was prepared by treating the commercially available N-methylanthranilamide with methyl iodide at 100 °C following a described protocol in: Chatterjee, A.; Majudmar, S. G. J. Am. Chem. Soc. 1953, 75, 4365-4366.
39. Primary amides have been reported to suffer Hofmann-type rearrangements using various iodine(III) reagents. However, in our case, such types of products were not detected. See: Prakash, O.; Batra, H.; Kaur, H.; Sharma, P. K.; Sharma, V.; Singh, S. P.; Moriarty, R. M. Synthesis 2001, 541-543.
40. Kawase, M.; Kitamura, T.; Kikugawa, Y. J. Org. Chem. 1989, 54, 3394-3403.